NEURIMMUNE Trademark

Trademark Overview


On Saturday, March 3, 2018, a trademark application was filed for NEURIMMUNE with the United States Patent and Trademark Office. The USPTO has given the NEURIMMUNE trademark a serial number of 87819026. The federal status of this trademark filing is REGISTERED as of Tuesday, November 17, 2020. This trademark is owned by Neurimmune Holding AG. The NEURIMMUNE trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

pharmaceutical preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapeutic purposes; pharmaceutical agents for the removal of tumors; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies for use in disease testing; vaccines; diagnostic preparations for medical purposes in the form of epitopes for detection of anomalies in proteins; pharmaceutical preparations, namely, synthetic peptides for use in the treatment of diseases of the CNS, metabolic disea...

medical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, physical examination for medical purposes; preparation of medicines, namely, pharmaceutical compounding services and dispensing of medicines in the nature of pharmaceuticals; healthcare services in the nature of nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care, namely, providing sanitary health care information; veterinary services; beauty salon services; care services for animals, namely, veterinary care services; hygienic care; consultancy and provision of medical information relating to the operation, preparation, administration and dosage of pharmaceutical preparations; advisory services relating to pharmaceuticals; providing medical information to healthcare professionals and patients in the form of compiled medical reports in the field of diagnostic, prophylactic and therapeutic properties of pharma...

monitoring, inspection, and analysis of biologically active chemical substances for quality control purposes; research on pharmaceutical products, cosmetics and foodstuffs for others; consultancy and information services in the field of monitoring and inspection for the quality control and analysis of biologically active chemical substances; research in the field of medical treatment and methods; research in the fields of biotechnology and antibodies; medical and scientific research information in the field of clinical trial testing and research in medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical manufacturing for quality control and scientific research purposes and research in the field of biology; computer software design; computer programming; maintenance of computer software; design and development of computer hardware; development of computer software; consultancy and provision of information relating t...
neurimmune

General Information


Serial Number87819026
Word MarkNEURIMMUNE
Filing DateSaturday, March 3, 2018
Status700 - REGISTERED
Status DateTuesday, November 17, 2020
Registration Number6197817
Registration DateTuesday, November 17, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 1, 2020

Trademark Statements


Description of MarkThe mark consists of the word "NEURIMMUNE" above a design consisting of four lines. Two diagonal lines in opposite directions converge to become parallel horizontal lines. The diagonal portions of the lines are flanked by one additional diagonal parallel line each.
Goods and Servicespharmaceutical preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; veterinary preparations for treating diseases of the nervous system, infectious diseases, neoplasms, diseases of the immune system, endocrine and metabolic diseases, diseases of the circulatory system, diseases of the eye; pharmaceutical preparations for immunotherapeutic purposes; pharmaceutical agents for the removal of tumors; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations, namely, immunogens; pharmaceutical preparations, namely, antibodies for use in disease testing; vaccines; diagnostic preparations for medical purposes in the form of epitopes for detection of anomalies in proteins; pharmaceutical preparations, namely, synthetic peptides for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; sanitary preparations for medical use; biological pharmaceutical and veterinary preparations for medical use being for the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections; pharmaceutical and veterinary biocides; diagnostic preparations for medical and veterinary purposes; sanitary towels for hygiene purposes; dietetic foods adapted for medical use; dietetic beverages adapted for medical use; biological pharmaceutical and veterinary preparations in the nature of protein antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNS, metabolic diseases, cardiovascular diseases, cancer, psychiatric diseases, infections, immunologic diseases, inflammatory diseases, respiratory diseases, psychological diseases for medical purposes; antibacterial pharmaceutical and veterinary preparations, namely, antibacterial substances for medical purposes, antibacterial pharmaceuticals; biopharmaceutical preparations for the treatment of cancer; protein dietary supplements
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesmedical services; medical services in the field of immunity; provision of medical information; medical examinations, namely, physical examination for medical purposes; preparation of medicines, namely, pharmaceutical compounding services and dispensing of medicines in the nature of pharmaceuticals; healthcare services in the nature of nutritional and dietary consultancy; consultancy and provision of information in the field of sanitary care, namely, providing sanitary health care information; veterinary services; beauty salon services; care services for animals, namely, veterinary care services; hygienic care; consultancy and provision of medical information relating to the operation, preparation, administration and dosage of pharmaceutical preparations; advisory services relating to pharmaceuticals; providing medical information to healthcare professionals and patients in the form of compiled medical reports in the field of diagnostic, prophylactic and therapeutic properties of pharmaceuticals; drug use screening services for medical purposes; information services relating to health care
Goods and Servicesmonitoring, inspection, and analysis of biologically active chemical substances for quality control purposes; research on pharmaceutical products, cosmetics and foodstuffs for others; consultancy and information services in the field of monitoring and inspection for the quality control and analysis of biologically active chemical substances; research in the field of medical treatment and methods; research in the fields of biotechnology and antibodies; medical and scientific research information in the field of clinical trial testing and research in medical treatment; research in the field of sanitary care; monitoring and inspection of biological synthesis and pharmaceutical manufacturing for quality control and scientific research purposes and research in the field of biology; computer software design; computer programming; maintenance of computer software; design and development of computer hardware; development of computer software; consultancy and provision of information relating to quality control of pharmaceutical preparations; scientific research in the field of cancerous diseases; scientific research relating to chemistry

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 9, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeurimmune Holding AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSchlieren 8952
CH

Party NameNeurimmune Holding AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSchlieren 8952
CH

Party NameNeurimmune Holding AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSchlieren 8952
CH

Trademark Events


Event DateEvent Description
Friday, November 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, January 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 21, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 17, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 1, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 1, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 27, 2020EXAMINERS AMENDMENT MAILED
Monday, July 27, 2020EXAMINER'S AMENDMENT AFTER PUB APPROVAL
Tuesday, July 14, 2020CASE RETURNED TO EXAMINATION
Tuesday, July 14, 2020NOTICE OF ALLOWANCE CANCELLED
Thursday, July 2, 2020ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Thursday, July 2, 2020PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, July 2, 2020ASSIGNED TO PETITION STAFF
Thursday, July 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 2, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 26, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, May 26, 2020TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, April 21, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 18, 2020SOU EXTENSION 3 GRANTED
Saturday, April 18, 2020SOU EXTENSION 3 FILED
Saturday, April 18, 2020SOU TEAS EXTENSION RECEIVED
Thursday, October 3, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 1, 2019SOU EXTENSION 2 GRANTED
Tuesday, October 1, 2019SOU EXTENSION 2 FILED
Tuesday, October 1, 2019SOU TEAS EXTENSION RECEIVED
Saturday, April 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2019SOU EXTENSION 1 GRANTED
Thursday, April 11, 2019SOU EXTENSION 1 FILED
Thursday, April 11, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 27, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 27, 2018EXAMINER'S AMENDMENT ENTERED
Friday, July 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2018EXAMINERS AMENDMENT E-MAILED
Friday, July 27, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, July 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, July 15, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, July 15, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 22, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 22, 2018NON-FINAL ACTION E-MAILED
Friday, June 22, 2018NON-FINAL ACTION WRITTEN
Friday, June 15, 2018ASSIGNED TO EXAMINER
Saturday, March 10, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 7, 2018NEW APPLICATION ENTERED